Literature DB >> 21679872

IgA pemphigus.

Daisuke Tsuruta1, Norito Ishii, Takahiro Hamada, Bungo Ohyama, Shunpei Fukuda, Hiroshi Koga, Kazuko Imamura, Hiromi Kobayashi, Tadashi Karashima, Takekuni Nakama, Teruki Dainichi, Takashi Hashimoto.   

Abstract

Pemphigus is a life-threatening autoimmune blistering disease. Pemphigus is divided into 4 major types; pemphigus vulgaris, pemphigus foliaceus, paraneoplastic pemphigus, and IgA pemphigus. Among them, IgA pemphigus is characterized by tissue-bound and circulating IgA antibodies targeting desmosomal or nondesmosomal cell surface components in the epidermis. Histopathologically, slight epidermal acantholysis and extensive neutrophilic infiltration in either the upper part or all layers of the epidermis were observed. IgA pemphigus is subdivided into intraepidermal neutrophilic IgA dermatosis-type (IEN-type), whose target antigen is still unknown (probably nondesmosomal cell surface protein), and subcorneal pustular dermatosis-type (SPD-type), whose target antigen is desmocollin 1 (Dsc1). We summarize reported cases of IgA pemphigus and describe current knowledge including epidemiology, clinical manifestations, pathology, laboratory tests, pathophysiology, associated diseases, prognosis and treatment, and future perspectives of IgA pemphigus.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679872     DOI: 10.1016/j.clindermatol.2011.01.014

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  11 in total

Review 1.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

Review 2.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

3.  IgA pemphigus showing IgA antibodies to desmoglein 1 and 3.

Authors:  Salama Hegazy; Sana Bouchouicha; Aida Khaled; Lilia Laadher; Maryem Kallel Sellami; Faten Zeglaoui
Journal:  Dermatol Pract Concept       Date:  2016-10-31

Review 4.  Validation studies of outcome measures in pemphigus.

Authors:  Sarah Hanna; Minhee Kim; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2016-12-10

Review 5.  Serological Diagnosis of Autoimmune Bullous Skin Diseases.

Authors:  Sandra Saschenbrecker; Ingolf Karl; Lars Komorowski; Christian Probst; Cornelia Dähnrich; Kai Fechner; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

Review 6.  Epidemiology of Pemphigus.

Authors:  Khalaf Kridin; Enno Schmidt
Journal:  JID Innov       Date:  2021-02-20

Review 7.  Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.

Authors:  Nina van Beek; Detlef Zillikens; Enno Schmidt
Journal:  Dtsch Arztebl Int       Date:  2021-06-18       Impact factor: 8.251

Review 8.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

Review 9.  Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus.

Authors:  Adriana Maria Porro; Livia de Vasconcelos Nasser Caetano; Laura de Sena Nogueira Maehara; Milvia Maria dos Santos Enokihara
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

10.  Systemic retinoids for treatment of recalcitrant IgA pemphigus.

Authors:  Franziska Schauer; Johannes Steffen Kern; Dimitra Kiritsi
Journal:  Orphanet J Rare Dis       Date:  2018-09-18       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.